Targeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training

Although the burden of heart failure with preserved ejection fraction (HFpEF) is increasing, there is no therapy available that improves prognosis. Clinical trials using beta blockers and angiotensin converting enzyme inhibitors, cardiac-targeting drugs that reduce mortality in heart failure with re...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oxid Med Cell Longev
Hlavní autoři: Gevaert, Andreas B., Lemmens, Katrien, Vrints, Christiaan J., Van Craenenbroeck, Emeline M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2017
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494585/
https://ncbi.nlm.nih.gov/pubmed/28706575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/4865756
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky